These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314 [TBL] [Abstract][Full Text] [Related]
17. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus: all roads lead to type I interferons. Pascual V; Farkas L; Banchereau J Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763 [TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus. Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588 [TBL] [Abstract][Full Text] [Related]
20. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells. Tsuzaka K; Setoyama Y; Yoshimoto K; Shiraishi K; Suzuki K; Abe T; Takeuchi T J Immunol; 2005 Mar; 174(6):3518-25. PubMed ID: 15749888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]